GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: ATB 346 | ATB-346 | ATB-346, (S)- | ATB346
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Otenaproxesul (ATB-346) is a novel, orally administered, gastrointestinal-sparing hydrogen sulfide (H2S)-releasing analgesic and anti-inflammatory drug in clinical trials for osteoarthritis [8]. Structurally it comprises an H2S-releasing moiety covalently linked to a NSAID (naproxen). H2S-releasing NSAIDs are in development for their potential analgesic, anti-inflammatory, cytoprotective and chemopreventative properties      [2-3,5-6,9-10].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Immunopharmacology Comments | 
| ATB-346 is an H2S-releasing NSAID. The liberation of H2S has the potential to reduce the gastrointestinal damage caused by long-term use of traditional NSAIDs, and may also enhance the anti-cancer effects of the NSAID drug [5]. | 
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References | 
| Osteoarthritis | Disease Ontology: 
                                                                        DOID:8398 | ATB-346 is a clinical trial candidate for OA. | |